E. Schneider

1.5k total citations
99 papers, 967 citations indexed

About

E. Schneider is a scholar working on Neurology, Immunology and Molecular Biology. According to data from OpenAlex, E. Schneider has authored 99 papers receiving a total of 967 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Neurology, 23 papers in Immunology and 18 papers in Molecular Biology. Recurrent topics in E. Schneider's work include Parkinson's Disease Mechanisms and Treatments (23 papers), Mast cells and histamine (11 papers) and Neurological disorders and treatments (8 papers). E. Schneider is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (23 papers), Mast cells and histamine (11 papers) and Neurological disorders and treatments (8 papers). E. Schneider collaborates with scholars based in Germany, France and United States. E. Schneider's co-authors include Michel Dy, P.-A. Fischer, Pedro Roberto Jacobi, Michel Dy, François Machavoine, Irène Gottlob, Wolfgang Heider, Wolfgang Skrandies, B. Lebel and Nathalie Thiéblemont and has published in prestigious journals such as Blood, The Journal of Immunology and Neurology.

In The Last Decade

E. Schneider

93 papers receiving 906 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Schneider Germany 17 401 280 187 152 136 99 967
Claire O’Leary United Kingdom 19 268 0.7× 274 1.0× 123 0.7× 307 2.0× 159 1.2× 44 1.2k
Jill Donelan United States 15 438 1.1× 299 1.1× 29 0.2× 258 1.7× 84 0.6× 19 1.2k
Ketan Patel United States 22 124 0.3× 547 2.0× 54 0.3× 185 1.2× 162 1.2× 48 1.7k
Şebnem Aktan Türkiye 18 152 0.4× 93 0.3× 75 0.4× 82 0.5× 96 0.7× 51 1.0k
Nicholas J. Van Wagoner United States 10 288 0.7× 246 0.9× 66 0.4× 108 0.7× 114 0.8× 19 909
Jan A. Marcusson Sweden 18 166 0.4× 115 0.4× 56 0.3× 197 1.3× 87 0.6× 52 1.1k
Ujjwal K. Rout United States 17 162 0.4× 240 0.9× 35 0.2× 44 0.3× 77 0.6× 35 927
Yoko Mizutani Japan 17 247 0.6× 391 1.4× 59 0.3× 56 0.4× 23 0.2× 61 1.1k
Mandy Busse Germany 21 367 0.9× 172 0.6× 91 0.5× 213 1.4× 68 0.5× 45 1.1k

Countries citing papers authored by E. Schneider

Since Specialization
Citations

This map shows the geographic impact of E. Schneider's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Schneider with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Schneider more than expected).

Fields of papers citing papers by E. Schneider

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Schneider. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Schneider. The network helps show where E. Schneider may publish in the future.

Co-authorship network of co-authors of E. Schneider

This figure shows the co-authorship network connecting the top 25 collaborators of E. Schneider. A scholar is included among the top collaborators of E. Schneider based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Schneider. E. Schneider is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schneider, E., et al.. (2025). A 50-year perspective on conservation challenges and legacy effects in temperate Patagonian forests. Biological Conservation. 306. 111124–111124. 2 indexed citations
2.
Kiltz, Uta, Martín Rudwaleit, Joachim Sieper, et al.. (2014). DGRh-S3-Leitlinie Axiale Spondyloarthritis inklusive Morbus Bechterew und Frühformen. Zeitschrift für Rheumatologie. 73(S2). 28–39. 7 indexed citations
3.
Kiltz, Uta, Martín Rudwaleit, Joachim Sieper, et al.. (2014). DGRh-S3-Leitlinie Axiale Spondyloarthritis inklusive Morbus Bechterew und Frühformen. Zeitschrift für Rheumatologie. 73(S2). 66–68.
4.
Kiltz, Uta, E. Schneider, B. Swoboda, et al.. (2014). DGRh-S3-Leitlinie Axiale Spondyloarthritis inklusive Morbus Bechterew und Frühformen. Zeitschrift für Rheumatologie. 73(S2). 97–100. 3 indexed citations
5.
Gohlke, H., Ch. Gohlke-Bärwolf, Katharina Peters, et al.. (2008). Prävention des Zigarettenrauchens in der Schule: Eine prospektive kontrollierte Studie. DMW - Deutsche Medizinische Wochenschrift. 114(46). 1780–1784. 2 indexed citations
6.
Baas, H., G. Fuchs, I Gemende, et al.. (2002). Which factors influence therapeutic decisions in Parkinson's disease?. Journal of Neurology. 249(0). 1–1. 1 indexed citations
7.
Schneider, E., François M. Lemoine, J Breton-Gorius, et al.. (1999). IL-3-induced coexpression of histidine decarboxylase, IL-4 and IL-6 mRNA by murine basophil precursors. Experimental Hematology. 27(6). 1010–1018. 27 indexed citations
8.
Schneider, E.. (1999). Autonome Störungen bei der Parkinson-Krankheit und deren Behandlung. Der Nervenarzt. 70(13). S26–S34. 2 indexed citations
9.
Schumm, Michael, E. Schneider, Elisabeth Kremmer, et al.. (1997). Immune phenotype of canine hematopoietic progenitor cells. Tissue Antigens. 50(5). 466–474. 7 indexed citations
10.
Schneider, E., et al.. (1995). Murine hematopoietic progenitor cells produce IL-6 in response to IgE.. PubMed. 23(4). 353–61. 1 indexed citations
11.
Herbelin, André, François Machavoine, Alain Vicari, et al.. (1994). Endogenous granulocyte-macrophage colony-stimulating factor is involved in IL-1- and IL-7-induced murine thymocyte proliferation.. The Journal of Immunology. 153(5). 1973–1981. 14 indexed citations
12.
Herbelin, André, François Machavoine, E. Schneider, M Papiernik, & Michel Dy. (1992). IL-7 is requisite for IL-1-induced thymocyte proliferation. Involvement of IL-7 in the synergistic effects of granulocyte-macrophage colony-stimulating factor or tumor necrosis factor with IL-1. The Journal of Immunology. 148(1). 99–105. 14 indexed citations
13.
Balabanova, S., et al.. (1990). Das Vorhandensein von Methadon im apokrinen Schwei� beim Menschen. International Journal of Legal Medicine. 103(5). 323–327. 8 indexed citations
14.
Baas, H., et al.. (1985). Mesulergine and bromocriptine in long-term treatment of advanced parkinsonism. Journal of Neural Transmission. 64(1). 45–54. 5 indexed citations
15.
Schneider, E.. (1982). Verweilmagnet in der Therapie der Reticulitis traumatica des Rindes. Schweizer Archiv für Tierheilkunde. 4 indexed citations
16.
Schneider, E., et al.. (1977). Relationship between arteriosclerosis and cerebral atrophy in parkinson's disease. Journal of Neurology. 217(1). 11–16. 6 indexed citations
17.
Schneider, E.. (1975). [Uroflowmetry in the diagnosis of neurogenic bladder disorders].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 46(4). 203–7.
18.
Kaiser, R. & E. Schneider. (1972). Die Beeinflussung der Mitosezahl von Endometriumcarcinomen durch 17-Hydroxynorprogesteroncapronat bei der Frau@@@The influence of 17-hydroxynorprogesteroncapronat on the mitosisrate of the endometriumcarcinoma in woman. 212(4). 397–400. 2 indexed citations
19.
Kaiser, R. & E. Schneider. (1972). Die Beeinflussung der Mitosezahl von Endometriumcarcinomen durch 17-Hydroxynorprogesteroncapronat bei der Frau. Archives of Gynecology and Obstetrics. 212(4). 397–400. 2 indexed citations
20.
Schneider, E., et al.. (1971). Alkoholdelir und Traumschlaf: Ergebnisse einer polygraphischen Nachtschlaf-EEG-Untersuchung bei Patienten nach Alkoholdelir. 214(2). 116–126. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Claire O’Leary Breakdown of academic impact, for papers by Jill Donelan Breakdown of academic impact, for papers by Ketan Patel Breakdown of academic impact, for papers by Şebnem Aktan Breakdown of academic impact, for papers by Nicholas J. Van Wagoner Breakdown of academic impact, for papers by Jan A. Marcusson Breakdown of academic impact, for papers by Ujjwal K. Rout Breakdown of academic impact, for papers by Yoko Mizutani Breakdown of academic impact, for papers by Mandy Busse
Rankless by CCL
2026